- Home
- ALV vs LNTH Comparison
ALV vs LNTH Comparison
Compare ALV & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALV | LNTH |
|---|---|---|
| Founded | 1953 | 1956 |
| Country | Sweden | United States |
| Employees | 65200 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 4.9B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | ALV | LNTH |
|---|---|---|
| Price | $103.84 | $77.57 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $134.40 | $83.20 |
| AVG Volume (30 Days) | 625.5K | ★ 948.3K |
| Earning Date | 04-17-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.31% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.41 |
| Revenue | N/A | ★ $343,374,000.00 |
| Revenue This Year | $2.55 | N/A |
| Revenue Next Year | $3.47 | $13.93 |
| P/E Ratio | ★ $13.10 | $22.27 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $76.18 | $47.27 |
| 52 Week High | $130.14 | $108.86 |
Technical Indicators
Market Signals| Indicator | ALV | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 55.74 |
| Support Level | $99.80 | $72.35 |
| Resistance Level | $128.33 | $80.91 |
| Average True Range (ATR) | 2.33 | 2.43 |
| MACD | 0.85 | -0.28 |
| Stochastic Oscillator | 56.29 | 60.09 |
Price Performance
Historical ComparisonAbout ALV Autoliv Inc.
Autoliv Inc is a developer, manufacturer, and supplier of passive safety systems to the automotive industry with a broad range of product offerings. Its product portfolio includes passive safety systems for commercial vehicles, battery cut-off switches, safety solutions for riders of motorcycles and bikes, airbags (including steering wheels and inflators), seatbelts, etc. Geographically, the group operates in the Americas, Europe, China, and Asia, excluding China, of which the maximum revenue is generated from its business in the Americas.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.